Digoxin Immune Fab how supplied storage and handling
| Digoxin Immune Fab |
|---|
| DIGIFAB® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Digoxin Immune Fab |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information about Digoxin immune fab, click here.
HOW SUPPLIED
DigiFab is supplied as a sterile, purified, lyophilized preparation. Each vial contains 40 mg of digoxin immune Fab protein, contains no preservatives and is intended for one time use.
Each box contains 1 vial of DigiFab.
NDC 0281-0365-10
Storage Conditions:
The product should be stored at 2° to 8°C (36° to 46°F). Do not freeze. The product must be used within 4 hours after reconstitution.
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6832767f-db6b-4eea-b88b-bdfc905749e1